Skip to main content

Table 1 Association of sex and allele frequency of the rs2232365 polymorphism in patients with chronic diseases, stratified according to the clinical-pathological profile

From: Sex and FOXP3 gene rs2232365 polymorphism may be associated with the clinical and pathological aspects of chronic viral diseases

  Sex Alleles (rs2232365)
Female (%)
Alleles (rs2232365)
Male (%)
Multiple logistic regression
Female (323) Male (373) Statistica T C Statistica T C Statistica
Group     349 (54.03) 297 (45.98) 188 (50.40) 185 (49.60)  
 CVLD 39 (12.07) 62 (16.62) 0.07 39 (50.00) 39 (50.00) 0.47 31 (50.00) 31 (50.00) 0.55 NS
 HTLV-1 44 (13.62) 23 (06.16) 0.03 1.91 (1.10–3.33) 52 (59.09) 36 (40.91) 0.62 7 (33.33) 16 (66.67) 0.05 0.36 (0.14–0.92) Sex*:
2.11 (1.18–3.75)
T*:
0.43 (0.20–0.95)
 CAD 91 (28.17) 139 (37.27) 0.02 1.53 (1.08–2.16) 93 (51.10) 89 (48.90) 0.41 68 (48.92) 71 (51.08) 0.35 Sex*:
1.44 (0.95–2.19)
 CG 149 (46.13) 149 (39.95)   165 (55.40) 133 (44.63)   82 (54.31) 67 (45.70)   
Inflammation (CVLD)
 A0-A1 24 (61.54) 43 (69.35) 0.52 24 (50.00) 24 (50.00) 1.0 20 (57.90) 23 (53.49) 0.58  
 A2-A3 15 (38.46) 19 (30.65)   15 (50.00) 15 (50.00)   11 (46.51) 8 (42.11)   
Fibrosis (CVLD)
 F0-F1 20 (51.28) 29 (46.77) 0.82 20 (50.00) 20 (50.00) 1.0 10 (34.48) 19 (65.52) 0.05 4.18 (1.13–15.4) T*:
1.11 (0.43–2.90)
 F2 8 (20.51) 17 (27.42)   8 (50.00) 8 (50.00)   10 (58.82) 7 (41.18)   
 F3-F4 11 (28.21) 16 (25.81)   11 (50.00) 11 (50.00)   11 (68.75) 5 (31.25)   
HTLV-1
 Asymptomatic 27 (61.36) 13 (61.90) 1.0 32 (59.26) 22 (40.74) 0.86 4 (30.77) 9 (69.23) 0.87  
 HAM/TSP 17 (38.64) 8 (38.10)   20 (58.82) 14 (41.18)   3 (37.50) 5 (62.50)   
Risky infections (CAD)
Chlamydia+ 78 (85.71) 121 (87.05) 0.84 80 (86.02) 74 (85.06) 1.0 60 (88.24) 61 (85.92) 0.80  
Chlamydia- 13 (14.29) 18 (12.95)   13 (13.98) 13 (14.94)   8 (11.76) 10 (14.08)   
Species of Chlamydia
C. pneumoniae 55 (70.51) 82 (67.77) 0.74 58 (70.73) 56 (66.67) 0.99 43 (71.67) 39 (63.93) 0.50  
C. trachomatis 3 (03.85) 3 (02.48)   2 (02.44) 2 (02.38)   2 (03.33) 1 (01.64)   
Coinfection 20 (25.64) 36 (29.75)   22 (26.83) 20 (23.81)   15 (25.00) 21 (34.43)   
  1. CVLD Chronic Viral Liver Diseases
  2. CAD Coronary Artery Disease
  3. CG Control Group
  4. ax2 test. Odds ratio (Confidence interval - 95%)
  5. *0.05 ≥ p ≥ 0.01
  6. **0.01 ≥ p ≥ 0.001